Skip to main content
Log in

Surprise results from ISIS-4 and GISSI-3

  • Newsletter Article
  • Published:
Inpharma Weekly

Abstract

A turnaround in cardiovascular medicine is likely to take place in light of the results of 2 major studies. To the surprise of many, magnesium was found to be of no benefit in patients with acute myocardial infarction (MI), nitrates had no effect on survival, and the survival benefit offered by ACE inhibitors was less than expected. In addition to influencing therapy choice, the trials also emphasised the importance of conducting ‘mega-trials’ to obtain reliable data on the effects of treatment regimens. The study results were presented at the 66th Sessions of the American Heart Association held in Atlanta, US, in November.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ryan, N., Higgins, G. Surprise results from ISIS-4 and GISSI-3. Inpharma Wkly. 914, 3–4 (1993). https://doi.org/10.2165/00128413-199309140-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128413-199309140-00004

Navigation